Company profile
Janpix company profile
Janpix is discovering and developing inhibitors of Signal Transducer and Activator of Transcription (“STAT”) proteins. Most members of this family of transcription factors have been known for some time and their relevance in certain cancers, in particular for STAT3 & STAT5, validated. Inhibiting the function of STAT proteins though has been very challenging thus far and Janpix developed new chemistry to address this complex problem.
Business identity
- Website
- https://www.janpixbio.com
- Operating status
- Closed
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $0-$1M
- Founded
- 2013-01-01, Year
Headquarters
- Headquarters
- Primghar, Iowa, United States
- Postal code
- 02142
- Country code
- US
- Continent
- North America